{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:27:06Z","timestamp":1761182826554,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2002]]},"DOI":"10.1007\/s10156-002-0198-2","type":"journal-article","created":{"date-parts":[[2003,12,10]],"date-time":"2003-12-10T18:53:01Z","timestamp":1071082381000},"page":"361-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A patient with primary human immunodeficiency virus infection for whom highly active antiretroviral therapy was successful"],"prefix":"10.1016","volume":"8","author":[{"given":"Norihiro","family":"Furusyo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwao","family":"Ariyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwao","family":"Ariyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arahito","family":"Mitsutake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seizaburo","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2000","series-title":"AIDS epidemic update December 2000","key":"10.1007\/s10156-002-0198-2_bib0005"},{"volume":"11(No. 2)","first-page":"1","year":"1999","key":"10.1007\/s10156-002-0198-2_bib0010"},{"key":"10.1007\/s10156-002-0198-2_bib0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s101560100024","article-title":"Effect of introduction of highly active antiretroviral treatment and the changes in patterns of drug-resistant HIV-1 in Japan","volume":"7","author":"Sugiura","year":"2001","journal-title":"J Infect Chemother"},{"key":"10.1007\/s10156-002-0198-2_bib0020","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/bmj.320.7248.1510","article-title":"Increase in high risk sexual behaviour among homosexual men London 1996-8: cross sectional questionnaire study","volume":"320","author":"Dodds","year":"2000","journal-title":"BMJ"},{"key":"10.1007\/s10156-002-0198-2_bib0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(85)91205-X","article-title":"Acute AIDS retrovirus infection Definition of a clinical illness associated with seroconversion","volume":"1","author":"Cooper","year":"1985","journal-title":"Lancet"},{"key":"10.1007\/s10156-002-0198-2_bib0030","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM199104043241405","article-title":"Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection","volume":"324","author":"Daar","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-002-0198-2_bib0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bmj.299.6692.154","article-title":"Clinical course of primary HIV infection: consequences for subsequent course of infection","volume":"299","author":"Pedersen","year":"1989","journal-title":"BMJ"},{"key":"10.1007\/s10156-002-0198-2_bib0040","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00002030-199506000-00011","article-title":"Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users Italian Seroconversion Study","volume":"9","author":"Dorrucci","year":"1995","journal-title":"AIDS"},{"key":"10.1007\/s10156-002-0198-2_bib0045","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jama.282.12.1142","article-title":"Reduced antiretroviral drug susceptibility among patients with primary HIV infection","volume":"282","author":"Little","year":"1999","journal-title":"JAMA"},{"key":"10.1007\/s10156-002-0198-2_bib0050","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jama.282.12.1135","article-title":"HIV- 1 drug resistance in newly infected individuals","volume":"282","author":"Boden","year":"1999","journal-title":"JAMA"},{"key":"10.1007\/s10156-002-0198-2_bib0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJM199807023390107","article-title":"Acute human immunodeficiency virus type 1 infection","volume":"339","author":"Kahn","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-002-0198-2_bib0060","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/infdis\/168.6.1490","article-title":"Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections","volume":"168","author":"Niu","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1007\/s10156-002-0198-2_bib0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-128-8-199804150-00001","article-title":"Biological and virologic characteristics of primary HIV infection","volume":"128","author":"Schacker","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1007\/s10156-002-0198-2_bib0070","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"key":"10.1007\/s10156-002-0198-2_bib0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/147323000203000310","article-title":"The effectiveness of antiretroviral drug therapy for HIV-1 associated with HIV-1 proviral DNA level and viral selection","volume":"30","author":"Ariyama","year":"2002","journal-title":"J Int Med Res"},{"key":"10.1007\/s10156-002-0198-2_bib0080","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1089\/088922200750054666","article-title":"HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment","volume":"16","author":"Burgard","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1007\/s10156-002-0198-2_bib0085","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJM199703273361304","article-title":"Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury","volume":"336","author":"Ridzon","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-002-0198-2_bib0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/317658","article-title":"Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load","volume":"183","author":"Celum","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1007\/s10156-002-0198-2_bib0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00002030-198802000-00008","article-title":"Genital ulceration as a risk factor for human immunodeficiency virus infection","volume":"2","author":"Greenblatt","year":"1988","journal-title":"AIDS"},{"key":"10.1007\/s10156-002-0198-2_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex Transm Infect"},{"key":"10.1007\/s10156-002-0198-2_bib0105","first-page":"117","article-title":"Outbreak of syphilis among men who have sex with men Southern California, 2000","volume":"50","year":"2001","journal-title":"MMWR"},{"key":"10.1007\/s10156-002-0198-2_bib0110","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1001\/jama.1997.03540480062040","article-title":"Antiretroviral therapy for HIV infection in 1997 Updated recommendations of the International AIDS Society-USA panel","volume":"277","author":"Carpenter","year":"1997","journal-title":"JAMA"},{"key":"10.1007\/s10156-002-0198-2_bib0115","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/516442","article-title":"Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection","volume":"175","author":"Lafeuillade","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1007\/s10156-002-0198-2_bib0120","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1056\/NEJM199905273402102","article-title":"Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy","volume":"340","author":"Furtado","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-002-0198-2_bib0125","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1086\/320189","article-title":"Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS","volume":"183","author":"Berrey","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1007\/s10156-002-0198-2_bib0130","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/bmj.309.6968.1535","article-title":"Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 \u00d7 10(6)\/l AIDS, and death from AIDS?","volume":"309","author":"Lindback","year":"1994","journal-title":"BMJ"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X02711872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X02711872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-002-0198-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:42:16Z","timestamp":1761158536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X02711872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002]]}},"alternative-id":["S1341321X02711872"],"URL":"https:\/\/doi.org\/10.1007\/s10156-002-0198-2","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2002]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A patient with primary human immunodeficiency virus infection for whom highly active antiretroviral therapy was successful","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-002-0198-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}